ABEONA THERAPEUTICS INC. Construction in Progress, Gross
ABEONA THERAPEUTICS INC. (ABEO) had Construction in Progress, Gross of $409.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:ConstructionInProgressGross · last filed 2019-03-18
- 2018-12-31: Construction in Progress, Gross $409.00K.
- 2017-12-31: Construction in Progress, Gross $455.00K.
- 2016-12-31: Construction in Progress, Gross $0.00.
| Period end | Construction in Progress, Gross |
|---|---|
| 2018-12-31 | $409.00K 10-K · filed 2019-03-18 |
| 2017-12-31 | $455.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |